KPV
FROM THE REEL TO THE RESEARCH
How far can inflammation research translate to people?
Explore the source-linked overview and studies below. Separate the proposed mechanism from outcomes measured in people, animals or cells.
What it is & what research shows
Reference overviewKPV is a three-amino-acid fragment derived from alpha-melanocyte-stimulating hormone. It is studied as an experimental anti-inflammatory and barrier-repair peptide, particularly in cell, gut and skin models. The cited research tested KPV in a biomaterial and inflammatory model rather than a human clinical trial. It provides mechanistic and preclinical context, not demonstrated human efficacy. [1.1][1.2]
A source-verified human half-life, clinical effectiveness, product quality and long-term safety are not established in the cited sources. Anti-inflammatory activity in a model does not establish a treatment effect in people. A source-linked study result with a verified dose and schedule is not yet available in this overview. This is a gap in this page, not a claim that no research exists. [2.1][2.2]
Sources & reading scope
- [1.1] KPV biomaterial and inflammatory researchPreclinical study · experimental hydrogel and inflammatory model
- [1.2] PubMed KPV peptide literature searchScientific database search · broader literature
- [2.1] KPV biomaterial and inflammatory researchPreclinical study · experimental hydrogel and inflammatory model
- [2.2] PubMed KPV peptide literature searchScientific database search · broader literature
Study-summary coverage
No completed study summaries are linked to this compound page yet. This is a coverage gap on PED Evidence, not evidence that human studies or other research do not exist.
Filter, save and compare KPV studies →More about KPV: identity, safety & reference details
Also known as lysine-proline-valine
Start with the research
An outcome-specific synthesis has not been prepared for this compound. This is a coverage gap, not evidence that it has no effect.
Open studies and trial records- Uses & research
The cited research tested KPV in a biomaterial and inflammatory model rather than a human clinical trial. It provides mechanistic and preclinical context, not demonstrated human efficacy. [1][2]
- Known half-life
No source-verified value in this profile yet. A treatment schedule or duration of an effect is not a drug half-life.
Half-life describes how quickly the measured drug concentration falls by half. It does not set a dosing interval.
Safety & evidence boundaries
A source-verified human half-life, clinical effectiveness, product quality and long-term safety are not established in the cited sources. Anti-inflammatory activity in a model does not establish a treatment effect in people.
Explore safety questions by system
These are literature filters, not claims that this compound causes each effect. A keyword match is not a confirmed adverse reaction.
Identity, names & formulations
Canonical compound: KPV · kpv
Searchable names: lysine-proline-valine
Names share a parent research page. Different esters, salts, routes and brands are not assumed to have the same half-life, indication or exposure.
Combination evidence stays attached to the studied combination. It is not automatically assigned to each ingredient.
Understand the evidence types
Read the model and design first, then the population, outcome and limitations. These categories describe evidence, not a best-compound ranking.
- Randomized human trials
- Compare assigned interventions. Randomization does not by itself establish low bias or relevance to every population.
- Controlled human studies
- Use a comparison group; allocation and confounding still matter.
- Prospective human research
- Follows participants forward. It may be observational or interventional, so this is not a separate quality grade.
- Observational human research
- Describes associations. Confounding can explain differences.
- Case reports and series
- Useful for unusual events and safety signals, not reliable rates or effect sizes.
- Animal research
- Can test biology and function in a living model. Human exposure, benefit and safety remain separate questions.
- Cell and tissue research
- Tests responses in a preparation, including human-derived cells. It is not a human participant trial.
- Mechanistic and computational evidence
- Helps explain or predict a pathway; predictions need experimental and clinical testing.
- Anecdotal reports
- Self-reported experiences can generate questions. Product identity, selection bias and other interventions may be uncontrolled.
Systematic reviews synthesize studies and depend on their quality. Preprint status and abstract versus full-paper reading are separate labels. Citation popularity measures attention, not reliability. A study summary is not a formal quality appraisal.
Sources for this profile
- 1. KPV biomaterial and inflammatory research Preclinical study · experimental hydrogel and inflammatory model
- 2. PubMed KPV peptide literature search Scientific database search · broader literature
Reference facts checked 2026-09-16. Source scope is listed above; this is not a formal quality appraisal. See each label for full prescribing information.
Study model describes the source. Confidence depends on methods, replication, population and outcome.
Loading compound research…